News|Articles|January 1, 2002

Kineret (Anakinra) AMGEN

Biologic: First IL-1 receptor blocker for moderate to severe rheumatoid arthritis


Related to this article

Stafeeva-stock@adobe.com
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.